GenAI can automate and accelerate many processes in the pharmaceutical industry, from drug discovery to clinical trials, resulting in faster development timelines and quicker time-to-market.

By integrating GenAI with legacy software and database tools, pharmaceutical companies can effectively monitor patient side effects once drugs are on the market.

Generative Artificial Intelligence (GenAI) refers to AI systems capable of creating new content, such as text, images, or even molecules, that are not explicitly programmed but generated through learning …

GenAI can help automate and streamline document management and compliance checks, but the cost savings might not be as pronounced as in other research-oriented phases.

4 days ago · Many pilots run in isolation: a sandboxed GenAI tool here, a use-case-specific solution there. But scaling GenAI across an enterprise means embedding it into workflows, not alongside them.

Jan 4, 2024 · Because the technology has such wide potential, pharmaceutical companies need to adopt a structured approach to implementing it. In BCG’s six-part framework for implementing …

Data conferences: Dedicated sessions on GenAI ranging from introductory to advanced covering a range of topics from opportunities to pitfalls, these conferences serve as a platform for knowledge …

Apr 29, 2025 · While excitement around GenAI is palpable, there’s an unmistakable pattern emerging: many organizations are still unsure how to operationalize GenAI beyond early discovery labs.

Jan 28, 2025 · By consolidating, analyzing, and providing insights on fragmented data, such a gen AI tool can help biopharma companies double the productivity of their supply chain organizations, …

Learn how to successfully integrate generative AI into your enterprise with IBM's 5-phase maturity model. This framework guides you from initial exploration to advanced, secure, and cost-optimized …